225 results on '"Giannelli, Valerio"'
Search Results
2. Immunosuppression in liver transplant oncology: position paper of the Italian Board of Experts in Liver Transplantation (I-BELT)
3. Correction to: Concurrent management of multiple sclerosis and natalizumab‑induced hepatitis with ofatumumab: a case report
4. Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study
5. Trends in liver transplantation for primary sclerosing cholangitis
6. Hepatological Evaluation and Biomarkers
7. Porto-sinusoidal vascular disorder (PSVD): Application of new diagnostic criteria in a multicenter cohort of patients
8. AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool
9. Hepatological Evaluation and Biomarkers
10. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation
11. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
12. Liver transplantation for sickle cell disease: a systematic review
13. Trends in liver transplantation for primary sclerosing cholangitis.
14. Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma
15. Superiority of the new sex‐adjusted models to remove the female disadvantage restoring equity in liver transplant allocation
16. Liver ischemia-reperfusion injury: From trigger loading to shot firing
17. Association between gut‐derived endotoxins and porto‐sinusoidal vascular disorder with portal hypertension
18. Response to: Letter to the Editor “Child‐Turcotte‐Pugh score as a model for organ allocation in liver transplantation, perhaps old is still gold”
19. Congenital extrahepatic portosystemic shunt: description of four cases and review of the literature
20. Response to: Importance of gender differences in body composition for liver transplantation and the ‘Sarco‐Model’ study
21. Porto-sinusoidal vascular disorder (PSVD): Application of new diagnostic criteria in a multicenter cohort of patients
22. The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients
23. Role of gut-derived endotoxins in porto-sinusoidal vascular disease
24. Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: risk of HCC recurrence from a large, multicentre retrospective study from Italy
25. Primary sclerosing cholangitis recurrence after liver transplantation: a nationwide survey in Italy
26. An overview on microbial population in liver cirrhosis : changing paradigm in the known bacteriology of spontaneous bacterial peritonitis
27. Superiority of the new sex‐adjusted models to remove the female disadvantage restoring equity in liver transplant allocation.
28. Misleading impaired liver function in a non-small-cell lung cancer patient treated with pembrolizumab: a case report
29. Liver ischemia-reperfusion injury: From trigger loading to shot firing.
30. AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool
31. Polyunsaturated fatty acids balance affects platelet NOX2 activity in patients with liver cirrhosis
32. Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy
33. SAT-009 Increased prevalence of metabolic-alcohol liver disease in Europe and of metabolic dysfunction-associated steatotic liver disease in the Americas. Results of the global IMPROVEMENT study
34. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation
35. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation
36. An empirical broad spectrum antibiotic therapy in health-care–associated infections improves survival in patients with cirrhosis: A randomized trial
37. Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients
38. Cirrhotic Patients Are at Risk for Health Care–Associated Bacterial Infections
39. Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients
40. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
41. The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis
42. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study
43. RE: re: manuscript titled, “Liver transplantation for sickle cell disease: a systematic review”
44. Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation
45. Resolution of primary hepatic marginal zone lymphoma in a hepatitis C virus-infected patient treated with a direct-acting antiviral
46. THU-323 - Role of gut-derived endotoxins in porto-sinusoidal vascular disease
47. THU-527 - Primary sclerosing cholangitis recurrence after liver transplantation: a nationwide survey in Italy
48. WED-340 - An overview on microbial population in liver cirrhosis : changing paradigm in the known bacteriology of spontaneous bacterial peritonitis
49. OS-069 - Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: risk of HCC recurrence from a large, multicentre retrospective study from Italy
50. Graft macrosteatosis and time of T-tube removal as risk factors for biliary strictures after liver transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.